OSTEOARTHRITIS: ITS PREVALENCE, RISK FACTORS, CLINICAL MANIFESTATION, DIAGNOSIS AND TREATMENT

(LITERATURE REVIEW)

Authors

  • F. Fiksman I. Horbachevsky Ternopil National Medical University
  • O. M. Krekhovska-Lepiavko I. Horbachevsky Ternopil National Medical University
  • B. A. Lokay I. Horbachevsky Ternopil National Medical University

DOI:

https://doi.org/10.11603/2411-1597.2022.4.13759

Abstract

Osteoarthritis is a degenerative joint disease that affects the cartilage, underlying bone, and synovial fluid. It is a leading cause of disability and chronic pain, affecting approximately 10 % of men and 18 % of women over the age of 60 worldwide . This literature review aims to summarize the current understanding of OA with regards to its prevalence, risk factors, clinical manifestation, diagnosis, and treatment.

References

The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study / M. Cross, E. Smith, D. Hoy [et al.] // Ann. Rheum. Dis. – 2020. – Vol. 73 (7). – P. 1323–1330. DOI: https://doi.org/10.1136/annrheumdis-2013-204763

Woolf A. D. Burden of major musculoskeletal conditions / A. D. Woolf, B. Pfleger // Bull. World Health Organ. – 2021. – Vol. 81 (9). – P. 646–656.

Vina E. R. Epidemiology of osteoarthritis: literature update / E. R. Vina, C. K. Kwoh // Curr. Opin. Rheumatol. – 2018. – Vol. 30 (2). – P. 160–167. DOI: https://doi.org/10.1097/BOR.0000000000000479

Neogi T. The epidemiology and impact of pain in osteoarthritis / T. Neogi // Osteoarthritis Cartilage. – 2013. – Vol. 21 (9). – P. 1145–1153. DOI: https://doi.org/10.1016/j.joca.2013.03.018

American College of Rheumatology 2012 recommen¬dations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee / M. C. Hochberg, R. D. Altman, K. T. April [et al.] // Arthritis Care Res. (Hoboken). – 2020. – Vol. 64 (4). – P. 465–474. DOI: https://doi.org/10.1002/acr.21596

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines / W. Zhang, G. Nuki, R. W. Moskowitz [et al.] // Osteoarthritis Cartilage. – 2008. – Vol. 16 (2). – P. 137–162. DOI: https://doi.org/10.1016/j.joca.2007.12.013

Henrotin Y. Natural products for promoting joint health and managing osteoarthritis / Y. Henrotin, A. Mobasheri // Curr. Rheumatol. Rep. – 2018. – Vol. 20 (11). – P. 72. DOI 10.1007/s11926-018-0772-4. PMID: 30284620. DOI: https://doi.org/10.1007/s11926-018-0782-9

OARSI guidelines for the non-surgical management of knee osteoarthritis / T. E. McAlindon, R. R. Bannuru, M. C. Sullivan [et al.] // Osteoarthritis Cartilage. – 2014. – Vol. 22 (3). – P. 363–388. DOI: https://doi.org/10.1016/j.joca.2014.01.003

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) / K. M. Jordan, N. K. Arden, M. Doherty [et al.] // Ann. Rheum. Dis. – 2003. – Vol. 62 (12). – P. 1145–1155. DOI: https://doi.org/10.1136/ard.2003.011742

Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure / E. M. Roos, H. P. Roos, L. S. Lohmander [et al.] // J. Orthop. Sports Phys. Ther. – 1998. – Vol. 28 (2). – P. 88–96. DOI: https://doi.org/10.2519/jospt.1998.28.2.88

Bedson J. Managing osteoarthritis in primary care: a review of the evidence base / J. Bedson, K. Jordan, P. Croft // Br. Med. Bull. – 2008. – Vol. 85 (1). – P. 45–59.

Published

2023-05-01

How to Cite

Fiksman, F., Krekhovska-Lepiavko, O. M., & Lokay, B. A. (2023). OSTEOARTHRITIS: ITS PREVALENCE, RISK FACTORS, CLINICAL MANIFESTATION, DIAGNOSIS AND TREATMENT: (LITERATURE REVIEW). Nursing, (4), 7–9. https://doi.org/10.11603/2411-1597.2022.4.13759

Issue

Section

Articles